#Japan #Minato #Spaceseed #Regenosome #LA-Bench

Regenosome Joins LA-Bench 2025 Competition

Regenosome Inc., a startup specializing in regenerative medicine and aging control technologies affiliated with Space Seed Holdings (based in Minato, Tokyo), has announced its participation in the upcoming AI competition, "LA-Bench 2025: Experiment Procedure Generation." This competition, hosted by the Laboratory Automation Association (LAA), focuses on evaluating AI capabilities to automatically generate detailed experimental procedures from natural language instructions.

The challenge requires a high level of expertise and reasoning within the fields of life sciences and chemistry. Regenosome intends to leverage its experience in longevity science research and space medicine applications to create a novel operational style within laboratory automation. By integrating experimental knowledge and tacit understanding into AI, the company aims to bridge intricate scientific practices with automated technology.

The Mission Behind Regenosome's Challenge

Regenosome is driven by a mission to provide aging-prevention technologies adaptable for terrestrial applications, necessary for supporting human life on the Moon by 2040. This research-driven, deep-tech startup utilizes extracellular vesicles (such as exosomes) as the foundation for its work. The goal is to not only extend healthspan but also establish technologies that allow humans to thrive in extraterrestrial environments.

This participation in LA-Bench is seen as a strategic move to expand Regenosome's core technologies into AI and robotics. The objective is to foster a collaborative environment where humans and AI work together in laboratories, thus accelerating innovation.

Insights from CEO Kengo Suzuki

Kengo Suzuki, CEO of Regenosome, stated, "The future of scientific research relies on the collaboration between 'AI that designs experiments' and 'robots that execute experiments.' We are determined to challenge ourselves by teaching AI the know-how of experiment design, honed through our work in longevity science and space-oriented research. I believe LA-Bench provides a valuable arena for competing intellectually with researchers worldwide."

Competition Overview

• - Name: LA-Bench 2025: Experiment Procedure Generation AI Competition
• - Hosted by: Laboratory Automation Association (LAA)
• - Supported by: AI Society Competition Support Program (FY 2025)
• - Official Site: LA-Bench Official Site

Key Schedule:

• - September 13, 2025: Official site launch and participant registration begins.
• - November 21, 2025: Submission deadline.
• - December 20, 2025: Results announcement.
• - June 2026: Awards ceremony at the National Conference of the AI Society.

About Regenosome Inc.

Regenosome is dedicated to providing innovative solutions for aging control and regenerative medicine using nanoparticles like exosomes. The company meticulously analyzes various cell-derived exosomes and works on molecular biological designs to uncover their functional potential within biological systems. Through this research, Regenosome aims to develop medical technologies utilizing nanoparticles and propose new solutions within space medicine, contributing to extending healthspan and supporting humanity's journey into space.
Learn more about Regenosome

About Space Seed Holdings

Space Seed Holdings operates as a deep tech venture builder with a mission to "turn science fiction into reality." Engaging in investment, research, and business development, the company fosters initiatives like the "Fermentation and Longevity Fund" to tackle societal challenges. With the ambition to acquire necessary technologies for human habitation in space by 2040, Space Seed is dedicated to collaborating with various stakeholders to make this vision a reality.
Learn more about Space Seed Holdings